$AGPU

Axe Compute Inc.

5
2
0
$98K
—
Zhu Theodore
0%
See all $AGPU insider activity →

AGPU sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 7 news stories mentioning AGPU (Axe Compute Inc.). Coverage has skewed bullish: 5 bullish, 2 neutral, and 0 bearish.

Recent AGPU coverage spans mergers & acquisitions, financial news and corporate actions.

In the last 30 days, AGPU insiders filed 2 SEC Form 4 transactions — 2 purchases ($98K) and no sales. The most active reporter was Zhu Theodore with 2 filings.

What's driving AGPU

AlphAI scores every news story that mentions AGPU with an AI model for sentiment and relevance, and aggregates insider trades from Axe Compute Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $AGPU

Score
$AGPUHigh

Axe Compute Inc. (AGPU): Completion of Acquisition or Disposition of Assets

Axe Compute Inc. (AGPU) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. Exhibit 99.1 Axe Compute Sells Helomics AI Cancer Diagnostics Lab Business to DataMEDS AI, Completing Transition to Neocloud GPU-as-a-Service platform September 15, 2026 All-stock sale gives Axe Compute equity stake in DataMEDS AI; aligns APU’s operating structure with its scalin

$MEDSMed

DataMeds AI, Inc. (MEDS): Entry into a Material Definitive Agreement

DataMeds AI, Inc. (MEDS) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Exhibit 99.1 PRESS RELEASE DATAMEDS AI, INC. 3000 BAYPORT DRIVE, SUITE 950 TAMPA, FLA. 33607 WEBSITE RUBENSTEIN PUBLIC RELATIONS CONTACT: JAMES LAMBERT 212-805-3024 JLAMBERT@RUBENSTEINPR.COM FOR IMMEDIATE RELEASE DATAMEDS, AI. ACQUIRES HELOMICS AI CANCER DIAGNOSTICS LAB AND PRECI

DataMEDS AI, Inc.: DataMEDS, AI. Acquires Helomics AI Cancer Diagnostics Lab and Precision Oncology CRO Businesses from Axe Compute

DataMEDS AI, Inc. (NASDAQ:MEDS) acquired Helomics, an AI cancer diagnostics lab, from Axe Compute (NASDAQ:AGPU) for $1.5 million in shares and notes. The deal includes a CLIA/CAP-certified lab and a precision oncology CRO business. DataMEDS plans to expand into cancer management, while Axe Compute focuses on AI infrastructure. The transaction has no third-party debt.

$AGPUMedAI 8/10

Axe Compute Inc (AGPU) (Q2 2026) Earnings Call Highlights: $3 Billion in New Contracts

Axe Compute Inc (AGPU) reported $3 billion in new contracts for Q2 2026, exceeding expectations. CEO Christopher Miglino highlighted $3.2 billion in total contract value (TCV) year-to-date. The company expects gross margins of 28-44% and EBITDA margins of 62-76% for Build projects, funded by customer down payments and project financing. A partnership with Duos Technologies added 55 megawatts across multiple locations. The company received a $317 million prepayment for a cluster expansion in Colu

Axe Compute and Duos Technologies Enter into Agreements For 55 MW of New AI Data Center Capacity Across Multiple U.S. Locations

Axe Compute (Nasdaq: AGPU) and Duos Technologies (Nasdaq: DUOT) announced agreements for up to 55 MW of new AI data center capacity across multiple U.S. locations, with expected aggregate payments of over $500 million. Projects are targeted to start late 2026 into early 2027. Axe Compute also plans minority investments via nonbinding term sheets.

$DUOTMedAI 8/10

Duos Technologies Signs Five-Year, 55 MW Hosting Agreements with Axe Compute Valued at Over $500 Million

Duos Technologies Group (Nasdaq: DUOT) said two project entities signed five-year hosting agreements with Axe Compute (Nasdaq: AGPU) for 55 MW of AI data center capacity across multiple U.S. sites. The deals are valued at over $500 million in aggregate base payments over five years, excluding electricity and usage charges. Initial readiness is targeted for late 2026 to early 2027.

Related tickers